{"database":"iProX","file_versions":[],"scores":null,"additional":{"omics_type":["Proteomics"],"submitter":["Xiaolong Liu"],"species":["Homo Sapiens"],"full_dataset_link":["http://www.iprox.org/page/project.html?id=IPX0006844000"],"submitter_email":["xiaoloong.liu@gmail.com"],"submitter_affiliation":["The Liver Center of Fujian Province"],"sample_protocol":[""],"repository":["iProX"],"data_protocol":[""],"additional_accession":[]},"is_claimable":false,"name":"Proteomic analysis identifies GSN as non-invasive circulating serum biomarker for predicting early recurrence in hepatocellular carcinoma","description":"Hepatocellular carcinoma (HCC) is susceptible to early recurrence and lacks effective predictive markers. Mass Spectrometry (MS)-based proteomics has emerged as a potent tool for identifying cancer biomarker profiles in various bodily fluids. In this study, we established a MS-based biomarker discovery and validation workflow. Firstly, the workflow successfully identified a total of 447 serum proteins in 179 individuals (126 HCC patients and 53 liver cirrhosis (LC)) using the Data Independent Acquisition-MS (DIA-MS) strategy. Then, candidate serum biomarkers were validated in 192 individuals (142 HCC patients and 50 LC patients) using Parallel Reaction Monitoring (PRM) strategy.","dates":{"publication":"Fri Dec 15 00:00:00 GMT 2023"},"accession":"PXD047852","cross_references":{"TAXONOMY":["9606"]}}